Jill Barrella, United States says,
"Seemed easy to purchase, reasonable prices. Good customer service when I used it."

Brian Pavey, United States says,
"I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."

Eric Gonzales, United States says,
"The website is very user friendly, there is a lot of variety and checking out was easy."

Albert Martinez, United States says,
"Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."

Natalie Wallace, United States says,
"I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."

Pfizer introduces anti-smoking drug 'Champix' in India

Posted Atnewstrackindia.com

US pharmaceutical giant Pfizer
Inc on Tuesday launched Varenicline drug in India
that help smokers to kick off smoking under the brand
name Champix.

After the drug spell a huge
success story in the US and Europe it is expected
to repeat the same here in India. So, now chain-smokers
have another option to tryor with an intense desire
to quit smoking.

The new drug, a non-nicotine
smoking cessation is considered as superior to nicotine
replacement therapy (NRT).

Varenicline helps the smoker
by diminishing the pleasurable effects of a fag and
thinning the craving for the same unlike the other
available drugs. The drug has to be taken for 12 weeks
and will be available first in major cities across
India with a cost of Rs 9,500.

During the launch of the
drug, Kewal Handa, the Managing Director of Pfizer
India, said, “Pfizer's Champix is the most innovative
and effective oral smoking cessation product to be
approved by the US FDA (Food and Drug Administration)
in the last 10 years.”

“It has benefited over
5.7 million people since its worldwide launch in mid-2006.
We are confident that Champix will provide the same
level of benefits to smokers in India and contribute
to a healthier world,” he added.

The drug is designed to provide
the necessary physiological and psychological support
to the smokers and research shows that Champix has
scored far better on chances of quitting smoking than
other drugs.

Champix is the first non-nicotine
drug and sure to help smokers if they want to say
good bye to this habit.

Smoking related deaths have
become a major concern but are also preventable. Many
addicted to smoking find it very difficult even if
they decided to kick it as nicotine in cigarette acts
a stimulant and is mainly responsible for dependence
forming properties of tobacco smoking. American Heart
Association defines Nicotine addiction as one of the
hardest addictions to break.

Recent Study

As per the latest report
supported by World Health Organisation (WHO) and Indian
government, at least one million people are going
to suffer smoking related deaths by 2010.

With an estimated total of
around 120 million (12 crore) in India the average
age of smokers vary from 30-69 including a one-third
of Men and about 5 per cent of Women. The study also
reveals that one of every five male deaths and one
out of every 20 female deaths are come about due to
smoking related diseases.

In a study conducted by New
England Journal of Medicine found that in India 61%
of men smokers will die at age 30-69 as compared to
41% non smokers. While 62% women smoker will die at
age 30-69 as compared to 38% non smokers.

Indian government has also
been tightening the laws by banning smoking in public
places to restrain the growing tobacco addiction among
young men and women. The recent laws imposed by health
ministry have banned direct and indirect ban of tobacco
products.

Hence, Champix holds a promise
for millions who realises strongly that smoking is
not only dangerous as it invites many diseases but
also proves to be fatal.

Trademark names that appear on this site are the property of each trademark holder.
We do not claim any affiliation with or to in any way connected to any manufacturer of offered products nor do we claim to be affiliated with or in any way connected to any holders of trademarks. Read more...